Kathleen A. Ryan

Kathleen A. Ryan

Auto-generated profile, based on publicly available information

Kathleen A. Ryan

Department of Medicine, (K.A.R.), University of Maryland School of Medicine, Baltimore, MD

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MVMarijana Vujkovic
Marijana Vujkovic
SRShweta Ramdas
Shweta Ramdas
KLKim M. Lorenz
Kim M. Lorenz
XGXiuqing Guo
Xiuqing Guo
RDRebecca Darlay
Rebecca Darlay
KCKyong-Mi Chang
Kyong-Mi Chang

14 September 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YCYanhua Chen
Yanhua Chen
XDXiaomeng Du
Xiaomeng Du
AKAnnapurna Kuppa
Annapurna Kuppa
MFMary Feitosa
Mary Feitosa
LBLawrence F. Bielak
Lawrence F. Bielak
ESElizabeth K. Speliotes
Elizabeth K. Speliotes

30 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
RSRosalie B. T. M. Sterenborg
Rosalie B. T. M. Sterenborg
ISInga Steinbrenner
Inga Steinbrenner
YLYong Li
Yong Li
MBMelissa N. Bujnis
Melissa N. Bujnis
TNTatsuhiko Naito
Tatsuhiko Naito
MMMarco Medici
Marco Medici
To date only a fraction of the genetic footprint of thyroid function has been clarified. We report a genome-wide association study meta-analysis of thyroid function in up to 271,040 individuals of European ancestry, including reference range thyrotropin (TSH), free thyroxine (FT4), free and total triiodothyronine (T3), proxies for metabolism (T3/FT4 ratio) as well as dichotomized high and low TSH levels. We revealed 259 independent significant associations for TSH (61% novel), 85 for FT4 (67% novel), and 62 novel signals for the T3 related traits. The loci explained 14.1%, 6.0%, 9.5% and 1.1% of the total variation in TSH, FT4, total T3 and free T3 concentrations, respectively. Genetic correlations indicate that TSH associated loci reflect the thyroid function determined by free T3, whereas the FT4 associations represent the thyroid hormone metabolism. Polygenic risk score and Mendelian randomization analyses showed the effects of genetically determined variation in thyroid function on various clinical outcomes, including cardiovascular risk factors and diseases, autoimmune diseases, and cancer. In conclusion, our results improve the understanding of thyroid hormone physiology and highlight the pleiotropic effects of thyroid function on various diseases.

1 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
WYWilliam J. Young
William J. Young
NLNajim Lahrouchi
Najim Lahrouchi
AIAaron Isaacs
Aaron Isaacs
TDThuyVy Duong
ThuyVy Duong
LFLuisa Foco
Luisa Foco
PMPatricia B. Munroe
Patricia B. Munroe
The QT interval is an electrocardiographic measure representing the sum of ventricular depolarization and repolarization, estimated by QRS duration and JT interval, respectively. QT interval abnormalities are associated with potentially fatal ventricular arrhythmia. Using genome-wide multi-ancestry analyses (>250,000 individuals) we identify 177, 156 and 121 independent loci for QT, JT and QRS, respectively, including a male-specific X-chromosome locus. Using gene-based rare-variant methods, we identify associations with Mendelian disease genes. Enrichments are observed in established pathways for QT and JT, and previously unreported genes indicated in insulin-receptor signalling and cardiac energy metabolism. In contrast for QRS, connective tissue components and processes for cell growth and extracellular matrix interactions are significantly enriched. We demonstrate polygenic risk score associations with atrial fibrillation, conduction disease and sudden cardiac death. Prioritization of druggable genes highlight potential therapeutic targets for arrhythmia. Together, these results substantially advance our understanding of the genetic architecture of ventricular depolarization and repolarization.

13 June 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
TWThomas W. Winkler
Thomas W. Winkler
HRHumaira Rasheed
Humaira Rasheed
ATAlexander Teumer
Alexander Teumer
MGMathias Gorski
Mathias Gorski
BRBryce X. Rowan
Bryce X. Rowan
IHIris M. Heid
Iris M. Heid
Reduced glomerular filtration rate (GFR) can progress to kidney failure. Risk factors include genetics and diabetes mellitus (DM), but little is known about their interaction. We conducted genome-wide association meta-analyses for estimated GFR based on serum creatinine (eGFR), separately for individuals with or without DM (nDM = 178,691, nnoDM = 1,296,113). Our genome-wide searches identified (i) seven eGFR loci with significant DM/noDM-difference, (ii) four additional novel loci with suggestive difference and (iii) 28 further novel loci (including CUBN) by allowing for potential difference. GWAS on eGFR among DM individuals identified 2 known and 27 potentially responsible loci for diabetic kidney disease. Gene prioritization highlighted 18 genes that may inform reno-protective drug development. We highlight the existence of DM-only and noDM-only effects, which can inform about the target group, if respective genes are advanced as drug targets. Largely shared effects suggest that most drug interventions to alter eGFR should be effective in DM and noDM.

3 December 2021 in Science
Verified
Journal Article
Closed access
MMMay E. Montasser
May E. Montasser
CHCristopher V. Van Hout
Cristopher V. Van Hout
LMLawrence Miloscio
Lawrence Miloscio
AHAlicia D. Howard
Alicia D. Howard
ARAvraham Rosenberg
Avraham Rosenberg
ASAlan R. Shuldiner
Alan R. Shuldiner
Rare variants and blood LDL cholesterol: A current goal in genomics is to identify genetic variation associated with actionable traits of clinical concern. Through exome sequencing of an Old Order Amish population, Montasser et al . identified a genetic variant that results in an amino acid change in the beta-1,4-galactosyltransferase 1 protein and is correlated with lower levels of cardiovascular disease. Investigation of the mutant protein showed that it affects genes associated with low-density lipoprotein cholesterol (LDL-C), and mice engineered to express the mutant protein exhibited a 38% decrease in blood LDL-C levels. This study suggests that such genomic sequencing and analysis can link genotype to phenotype and identify potentially clinically actionable pathways to treat disease. —LMZ